相似文献
1
Thymidine-dependent Escherichia coli infection and some associated laboratory problems.依赖胸苷的大肠杆菌感染及一些相关的实验室问题。
J Clin Pathol. 1974 Jul;27(7):565-8. doi: 10.1136/jcp.27.7.565.
2
Thymine dependent strains of Escherichia coli selected by trimethoprim-sulphamethoxazole therapy.
Pathology. 1974 Apr;6(2):161-7. doi: 10.3109/00313027409068980.
3
Role of thymidine for the activity of trimethoprim, sulfonamides and their combinations.胸苷对甲氧苄啶、磺胺类药物及其组合活性的作用。
Zentralbl Bakteriol A. 1980;247(4):483-94.
4
Co-trimoxazole in cases of gram-negative septicaemia.复方新诺明用于革兰氏阴性菌败血症病例。
Scand J Infect Dis Suppl. 1976(8):96-102.
5
Prophylactic efficacy of nitrofurantoin macrocrystals and trimethoprim-sulfamethoxazole in urinary infections. Biologic effects on the vaginal and rectal flora.呋喃妥因大晶体和甲氧苄啶-磺胺甲恶唑对尿路感染的预防效果。对阴道和直肠菌群的生物学效应。
N Engl J Med. 1977 Apr 7;296(14):780-3. doi: 10.1056/NEJM197704072961403.
6
Thymidine-dependent strain of Salmonella oslo selected by trimethoprim-sulfamethoxazole therapy.
Am J Clin Pathol. 1977 Aug;68(2):307-11. doi: 10.1093/ajcp/68.2.307.
7
Treatment of recurrent bacteriuria with pivmecillinam (FL 1039).
J Antimicrob Chemother. 1975 Jun;1(2):193-6. doi: 10.1093/jac/1.2.193.
8
[Models of urinary infection].[泌尿系统感染模型]
Zentralbl Bakteriol Orig A. 1974;227(1-4):298-305.
9
Short-term treatment of patients with chronic and recurrent urinary tract infections with co-trimoxazole.
Urol Res. 1973 Dec;1(4):152-6. doi: 10.1007/BF00256615.
10
Comparative therapeutic activities of ciprofloxacin, amoxicillin, ceftriaxone and co-trimoxazole in a new model of experimental infection with Escherichia coli.环丙沙星、阿莫西林、头孢曲松和复方新诺明在新型大肠杆菌实验感染模型中的比较治疗活性
Infection. 1986 Jul-Aug;14(4):190-4. doi: 10.1007/BF01645262.
引用本文的文献
1
Time-Kill Studies of Trimethoprim/Sulfamethoxazole against Stenotrophomonas maltophilia versus Escherichia coli Using Cation-Adjusted Mueller-Hinton Broth and ISO-Sensitest Broth.使用阳离子调整 Mueller-Hinton 肉汤和 ISO-Sensitest 肉汤对嗜麦芽寡养单胞菌与大肠杆菌进行复方磺胺甲噁唑/甲氧苄啶的时间杀菌研究。
Antimicrob Agents Chemother. 2022 Mar 15;66(3):e0216721. doi: 10.1128/aac.02167-21. Epub 2022 Jan 10.
2
Inactivation of thyA in Staphylococcus aureus attenuates virulence and has a strong impact on metabolism and virulence gene expression.金黄色葡萄球菌中thyA的失活会减弱其毒力，并对代谢和毒力基因表达产生强烈影响。
mBio. 2014 Jul 29;5(4):e01447-14. doi: 10.1128/mBio.01447-14.
3
Synergistic antimicrobial activities of folic acid antagonists and nucleoside analogs.叶酸拮抗剂和核苷类似物的协同抗菌活性。
Antimicrob Agents Chemother. 2010 Mar;54(3):1226-31. doi: 10.1128/AAC.00705-09. Epub 2009 Dec 22.
4
In vivo mutations of thymidylate synthase (encoded by thyA) are responsible for thymidine dependency in clinical small-colony variants of Staphylococcus aureus.胸苷酸合成酶（由thyA编码）的体内突变是金黄色葡萄球菌临床小菌落变异体中胸苷依赖性的原因。
J Bacteriol. 2008 Feb;190(3):834-42. doi: 10.1128/JB.00912-07. Epub 2007 Sep 28.
5
Infection caused by thymidine-requiring, trimethoprim-resistant bacteria.由需要胸苷、对甲氧苄啶耐药的细菌引起的感染。
J Clin Microbiol. 1983 Jul;18(1):79-83. doi: 10.1128/jcm.18.1.79-83.1983.
6
Catalase-negative Escherichia coli isolated from blood.从血液中分离出的过氧化氢酶阴性大肠杆菌。
J Clin Microbiol. 1978 May;7(5):474-8. doi: 10.1128/jcm.7.5.474-478.1978.
本文引用的文献
1
Reversal of the antimicrobial activity of trimethoprim by thymidine in commercially prepared media.在商业制备的培养基中，胸腺嘧啶核苷可逆转甲氧苄啶的抗菌活性。
Appl Microbiol. 1971 Nov;22(5):812-7. doi: 10.1128/am.22.5.812-817.1971.
2
Thymine-requiring mutants of Proteus mirabilis selected by co-trimoxazole in vivo.
J Gen Microbiol. 1973 Aug;77(2):533-5. doi: 10.1099/00221287-77-2-533.
3
Characteristics of some co-trimoxazole-resistant Enterobacteriaceae from infected patients.感染患者中部分耐复方新诺明肠杆菌科细菌的特征。
J Clin Pathol. 1972 Dec;25(12):1086-8. doi: 10.1136/jcp.25.12.1086.
4
Joint trimethoprim and sulphamethoxazole resistance in bacteria infected with R factors.感染R因子的细菌对甲氧苄啶和磺胺甲恶唑的联合耐药性。
J Med Microbiol. 1973 Feb;6(1):13-9. doi: 10.1099/00222615-6-1-13.
5
Sensitivity testing with trimethorpim-sulphamethoxazole.用甲氧苄啶-磺胺甲恶唑进行敏感性测试。
Med J Aust. 1973 Jun 30;1(2):Suppl:10-8.
Zotero 插件